Northrop Grumman (NOC) delivered stronger results than I expected in 2026, with a record $109.6 billion backlog and robust project execution. NOC's Aeronautics segment outperformed, with 14.41% revenue and 135.67% EBIT growth, driven by B-21 and F-35 volume and margin recovery. Relative valuation frameworks indicate 22–54% upside potential for NOC, supporting a reiterated BUY rating despite margin and contract risks.
Northrop Grumman targets 5%-7% sales growth in 2027, backed by a record backlog and B-21 investments, while higher capital spending adds execution challenges.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Backlog reached $110 billion with a 1.5x book-to-bill ratio. Management projects sales growth from 5% to 7% in 2027.
Northrop Grumman NYSE: NOC reported third-quarter 2026 sales growth across all four business segments, record backlog and higher earnings guidance, as the defense contractor cited demand for strategic deterrence, space systems, missile production and autonomous technologies.
While the top- and bottom-line numbers for Northrop Grumman (NOC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
NOC's Q3 2026 earnings beat estimates as revenues rise 6.7%, backlog reached $109.6B, and the company raised its full-year earnings outlook.
Northrop Grumman (NOC) came out with quarterly earnings of $7.89 per share, beating the Zacks Consensus Estimate of $7.22 per share. This compares to earnings of $7.67 per share a year ago.
Northrop said the quarter reflected strong demand for its global capabilities as the company had gains across all its units: aeronautics sales rose 14%, while defense sales increased 12% and its mission and space sales inched up 2% each.
Northrop lifts 2026 profit forecast on strong defense demand, record backlog
The U.S. Air Force chose Anduril and General Atomics to produce Collaborative Combat Aircraft for it, rejecting Northrop Grumman's offering. Northrop Grumman is proceeding to develop its YFQ-48A Talon Blue drone anyway.
NOC is advancing its precision weapons portfolio with a new grenade launcher and a Barrett partnership to tap growing demand for counter-drone systems.